Last 39.00 GBp
Change Today +3.25 / 9.09%
Volume 79.2K
AKT On Other Exchanges
Symbol
Exchange
London
Munich
OTC US
As of 11:35 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

ark therapeutics group plc (AKT) Snapshot

Open
35.00 GBp
Previous Close
35.75 GBp
Day High
40.50 GBp
Day Low
35.00 GBp
52 Week High
03/21/14 - 58.00 GBp
52 Week Low
03/2/15 - 27.50 GBp
Market Cap
5.4M
Average Volume 10 Days
36.4K
EPS TTM
-1.39 GBp
Shares Outstanding
14.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ARK THERAPEUTICS GROUP PLC (AKT)

Related News

No related news articles were found.

ark therapeutics group plc (AKT) Related Businessweek News

No Related Businessweek News Found

ark therapeutics group plc (AKT) Details

Ark Therapeutics Group plc does not have significant operations. Prior to March 15, 2013, the company was engaged in the provision of contract development and manufacturing services to the pharmaceutical and biotech industry. Ark Therapeutics Group plc was incorporated in 2001 and is based in London, the United Kingdom.

4 Employees
Last Reported Date: 04/29/14
Founded in 2001

ark therapeutics group plc (AKT) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ark therapeutics group plc (AKT) Key Developments

Ark Therapeutics Group plc Announces Changes to the Management Team

As outlined in the Circular and the Prospectus the following changes to the Ark Therapeutics Group plc's Board of Directors have also taken place on February 27, 2015. Dr. David Venables and Dr. David Bloxham have resigned as Non-Executive Directors with immediate effect. Mrs. Steven has also resigned as a Non-Executive Director but will continue as Company Secretary. Dominic Tonner, Daniel Smith and Rajan Uppal have been appointed Executive Directors in the roles of Chief Executive Officer, Chief Financial Officer and Corporate Development Director respectively with immediate effect.

Ark Therapeutics Group plc Approves Amendments to Articles of Association

Ark Therapeutics Group plc at the AGM held on 11 December 2014, shareholders approved amendments to Articles of Association.

Ark Therapeutics Group plc, Special/Extraordinary Shareholders Meeting, Dec 11, 2014

Ark Therapeutics Group plc, Special/Extraordinary Shareholders Meeting, Dec 11, 2014., at 10:30 GMT Standard Time. Location: at the offices of Marriott Harrison LLP, 11 Staple Inn.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKT:LN 39.00 GBp +3.25

AKT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AKT.
View Industry Companies
 

Industry Analysis

AKT

Industry Average

Valuation AKT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARK THERAPEUTICS GROUP PLC, please visit www.arktherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.